Skip to main content

Optic Atrophy, Ophthalmoplegia, Myopathy, and Neuropathy

OMIM ID:

autosomal dominant

Optic Atrophy, Ophthalmoplegia, Myopathy, and Neuropathy

Alternate Names

dominant optic atrophy plus syndrome
DOA+

Defective Genes

OPA1

Clinical Characteristics

Ocular Features

Visual symptoms have an insidious onset in childhood with vision loss and progressive external ophthalmoplegia.  Ptosis may be evident later.  The optic atrophy is progressive.   ERG abnormalities have been reported but no pigmentary retinopathy has been seen.  Myopia is sometimes present.

Systemic Features

The extraocular signs and symptoms are variable and generally have a later onset.  Some patients have an early onset of sensorineural hearing loss.  Muscle cramps and hyperreflexia may occur with clonus and a spastic gait.  Ataxia seems to be common.  The neurological phenotype has been likened to muscular sclerosis, Kearns-Sayre syndrome, and spastic paraplegia.  Muscle biopsies show variable-sized and atrophic fibers.

Genetics

Inheritance

This is generally considered an autosomal dominant disorder secondary to mutations in the OPA1 gene.  It is allelic to optic atrophy 1 (165500) but may also be the same condition since the p.Arg247His mutation has been found in patients with both disorders.  This syndromic form of optic atrophy may also result from biallelic mutations in OPA1 in which the clinical disease is more severe and earlier in onset. 

Pedigree

Autosomal dominant

Autosomal dominant disorders require only one mutation for the disease to be expressed.  Since an affected parent has two chromosomes, only one of which has the mutant gene, parents can expect that half (50%) of their children will receive that one and inherit the disease.  It is common for individuals that inherit the mutation, however, to not have evidence of the disease (nonpenetrance).

Image
Sample pedigree of autosomal dominant inheritance

Autosomal dominant inheritance leads to a vertical pattern of transmission

Treatment & Management

No treatment is available for the neurological disease but low vision aids should be considered to selected patients especially during childhood educational activities.

Selected Resources

Publications

Displaying 1 - 2 of 2

Dominant Optic Atrophy, Deafness, Ptosis, Ophthalmoplegia, Dystaxia, and Myopathy

PubMedID: 6493699

Multi-system neurological disease is common in patients with OPA1 mutations

PubMedID: 20157015